VOR Stock Analysis: Buy, Sell, or Hold?
VOR - Vor Biopharma Inc. Common Stock
$14.63
-0.44 (-2.92%)
▼
5d:
-13.64%
30d:
-2.27%
90d:
+14.48%
WAIT
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When VOR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: VOR is down 13.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: VOR is down 13.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: VOR is currently trading at $14.63, which is considered fair relative to its 30-day fair value range of $14.53 to $16.39.
Technical Outlook: Technically, VOR is in a strong uptrend. Immediate support is located at $13.66, while resistance sits at $18.28.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $37.88 (+158.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VOR is in a strong uptrend. Immediate support is located at $13.66, while resistance sits at $18.28.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $37.88 (+158.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$14.53 -
$16.39
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 158.9% below Wall St target ($37.88)
- WARNING: Recommendation downgraded due to -13.6% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$14.53 -
$16.39
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$13.66
Resistance Level
$18.28
Current Trend
Strong Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.22
Wall Street Target
$37.88
(+158.9%)
Share & Embed Analysis
Last updated: May 18, 2026 8:53 AM ET
Data refreshes hourly during market hours. Next update: 9:53 AM
Data refreshes hourly during market hours. Next update: 9:53 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VOR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
11
Sells
Net
INSIDERS SELLING
Recent Transactions
Ra Capital Management, L…
SELL
165150 shares
2026-04-22
Ra Capital Management, L…
SELL
171963 shares
2026-04-20
Ra Capital Management, L…
SELL
458411 shares
2026-04-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 63 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 50 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 55 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$293 | 60 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 42 HOLD |
